Yahoo Web Search

Search results

    • AbbVie makes oncology progress with two drug trials

      Crain s Chicago Business· 6 days ago

      Multiple myeloma, the second-most common blood cancer, is characterized by abnormal proliferation of plasma cells, which can cause end-organ damage, AbbVie said in a statement. The start of ...

    • Newswise Expert | Alok Khorana, Case Western Reserve University

      Newswise· 6 days ago

      ...Medicine, Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, the Sondra and Stephen Hardis Chair in Oncology Research, Vice-Chair for Clinical Services of the Taussig Cancer Institute (part of Case Comprehensive Cancer Center) and Director of the...